- Home
- LSB vs RCG Comparison
LSB vs RCG Comparison
Compare LSB & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- RCG
- Stock Information
- Founded
- LSB 2002
- RCG 1994
- Country
- LSB China
- RCG United States
- Employees
- LSB N/A
- RCG N/A
- Industry
- LSB
- RCG Investment Managers
- Sector
- LSB
- RCG Finance
- Exchange
- LSB NYSE
- RCG Nasdaq
- Market Cap
- LSB 22.3M
- RCG 18.2M
- IPO Year
- LSB N/A
- RCG N/A
- Fundamental
- Price
- LSB $1.10
- RCG $2.65
- Analyst Decision
- LSB
- RCG
- Analyst Count
- LSB 0
- RCG 0
- Target Price
- LSB N/A
- RCG N/A
- AVG Volume (30 Days)
- LSB 818.1K
- RCG 5.9K
- Earning Date
- LSB 07-22-2025
- RCG 01-01-0001
- Dividend Yield
- LSB N/A
- RCG 0.98%
- EPS Growth
- LSB N/A
- RCG N/A
- EPS
- LSB N/A
- RCG N/A
- Revenue
- LSB $79,415,311.00
- RCG N/A
- Revenue This Year
- LSB $39.33
- RCG N/A
- Revenue Next Year
- LSB $75.61
- RCG N/A
- P/E Ratio
- LSB N/A
- RCG N/A
- Revenue Growth
- LSB N/A
- RCG N/A
- 52 Week Low
- LSB $0.36
- RCG $1.52
- 52 Week High
- LSB $6.82
- RCG $1.90
- Technical
- Relative Strength Index (RSI)
- LSB 50.39
- RCG 51.92
- Support Level
- LSB $0.93
- RCG $2.60
- Resistance Level
- LSB $1.48
- RCG $2.71
- Average True Range (ATR)
- LSB 0.11
- RCG 0.07
- MACD
- LSB 0.03
- RCG 0.00
- Stochastic Oscillator
- LSB 30.51
- RCG 62.50
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.